Effect of N-chlorotaurine on Aspergillus, with particular reference to destruction of secreted gliotoxin

Journal of Medical Microbiology

Volumn 55, Issue 7, 2006, Pages 913-918

  Reeves, Emer P ^a   Nagl, Markus ^b   O'Keeffe, Joseph ^a   Kelly, Judy ^a   Kavanagh, Kevin ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM CHLORIDE; GLIOTOXIN; N CHLOROTAURINE; TAURINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS; ASPERGILLUS FUMIGATUS; DISULFIDE BOND; FUNGICIDAL ACTIVITY; HALOGENATION; NEUTROPHIL; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; GLIOTOXIN; HUMANS; MICROBIAL SENSITIVITY TESTS; QUATERNARY AMMONIUM COMPOUNDS; TAURINE;

EID: 33745654999     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46405-0     Document Type: Article

References (37)

1. Amitani, R., Murayama, T., Nawada, R., Lee, W. J., Niimi, A., Suzuki, K., Tanaka, E. & Kuze, F. (1995). Aspergillus culture filtrates and sputum sols from patients with pulmonary aspergillosis cause damage to human respiratory ciliated epithelium in vitro. Eur Respir J 8, 1681-1687.
2. Brakhage, A. A. & Langfelder, K. (2002). Menacing mold: the molecular biology of Aspergillus fumigatus. Annu Rev Microbiol 56, 433-455.
3. Cohen, B. E. (1998). Amphotericin B toxicity and lethality: a tale of two channels. Int J Pharm 162, 95-106.
4. Daly, P. & Kavanagh, K. (2001). Pulmonary aspergillosis: clinical presentation, diagnosis and therapy. Br J Biomed Sci 58, 197-205.
5. Fraser, R. S. (1993). Pulmonary aspergillosis: pathologic and pathogenetic features. Pathol Annu 28, 231-277.
6. Gottardi, W. & Nagl, M. (2002). Chemical properties of N-chlorotaurine sodium, a key compound in the human defence system. Arch Pharm Pharm (Weinheim) 9, 411-421.
7. Gottardi, W. & Nagl, M. (2005). Chlorine covers on living bacteria: the initial step in antimicrobial action of active chlorine compounds. J Antimicrob Chemother 55, 475-482.
8. Grisham, M., Jefferson, M., Melton, D. & Thomas, E. (1984). Chlorination of endogenous amines by isolated neutrophils. Ammonia-dependent bactericidal, cytotoxic and cytolytic activities of the chloramines. J Biol Chem 259, 10404-10413.
9. Hogan, L. H., Klein, B. S. & Levitz, S. M. (1996). Virulence factors of medically important fungi. Clin Microbiol Rev 9, 469-488.
10. Klebanoff, S. J. (1980). Oxygen metabolism and the toxic properties of phagocytes. Ann Intern Med 93, 480-489.
11. Marcinkiewiez, J. (2003). Prostanoids and MPO-halide system products as a link between innate and adaptive immunity. Immunol Lett 89, 187-191.
12. Müllbacher, A. & Eichner, R. D. (1984). Immunosuppression in vitro by a metabolite of a human pathogenic fungi. Proc Natl Acad Sci U S A 81, 3835-3837.
13. Nagl, M. & Gottardi, W. (1996). Enhancement of the bactericidal efficacy of N-chlorotaurine by inflammation samples and selected N-H compounds. Hyg Med 21, 597-605.
14. Nagl, M., Hess, M. W., Pfaller, K., Hengster, P. & Gottardi, W. (2000a). Bactericidal activity of micromolar N-chlorotaurine: evidence for its antimicrobial function in the human defence system. Antimicrob Agents Chemother 44, 2507-2513.
15. Nagl, M, Teuchner, B., Pottinger, E., Ulmer, H. & Gottardi, W. (2000b). Tolerance of N-chlorotaurine, a new antimicrobial agent, in infectious conjunctivitis - a phase II pilot study. Ophthalmologica 214, 111-114.
16. Nagl, M., Lass-Florl, C., Neher, A., Gunkel, A. & Gottardi, W. (2001). Enhanced fungicidal activity of N-chlorotaurine in nasal secretion. J Antimicrob Chemother 47, 871-874.
17. Nagl, M., Gruber, A., Fuchs, A., Lell, C. P., Lamberger, E. M., Borgvon Zepelin, M. & Wurzner, R. (2002). Impact of N-chlorotaurine on viability and production of secreted asparlyl proteinases of Candida spp. Antimicrob Agents Chemother 46, 1996-1999.
18. Nagl, M., Nguyen, V. A., Gottardi, W., Ulmer, H. & Hopfl, R. (2003). Tolerability and efficacy of N-chlorotaurine in comparison with chloramine T for the treatment of chronic leg ulcers with a purulent coating: a randomized phase II study. Br J Dermatol 149, 590-597.
19. Neher, A., Nagl, M., Appenroth, E., Gstottner, M., Wischatta, M., Reisigl, F., Schindler, M., Ulmer, H. & Stephan, K. (2004). Acute otitis externa: efficiency and tolerability of N-chlorotaurine, a novel endogenous antiseptic agent. Laryngoscope 114, 850-854.
20. 558 in the activation of the human neutrophil NADPH oxidase. Inject Immun 73, 735-244.
21. Park, E., Schuller Levis, G. & Quinn, M. R. (1995). Taurine chlorine-inhibits production of nitric oxide and TNF-alpha in activated RAW 264.7 cells by mechanisms that involve transcriptional and translational events. J Immunol 154, 4778-4784.
22. + flux. Nature 416, 291-296.
23. Reeves, E. P., Murphy, T., Daly, P. & Kavanagh, K. (2004). Amphotericin B enhances the synthesis and release of the immunosuppressive agent gliotoxin from the pulmonary pathogen Aspergillus fumigatus. J Med Microbiol 53, 719-725.
24. Richard, J. L. & DeBey, M. C. (1995). Production of gliotoxin during pathogenic state in turkey poults by Aspergillus fumigatus, Fresenius. Mycopathologia 129, 111-115.
25. Richard, J. L., Dvorak, T. J. & Ross, P. F. (1996). Natural occurrence of gliotoxin in turkeys infected with Aspergillus fumigatus, Fresenius. Mycopathologia 134, 167-170.
26. Sabatelli, F. J., Leobenberg, D., Mendrick, A., Patel, R., Norris, C. & McNicholas, P. M. (2004). In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against approximately 18,000 strains of clinically significant yeasts and moulds. Abstract from 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC.
27. Shah, D. T., Glover, D. D. & Larsen, B. (1995). In situ mycotoxin production by Candida albicans in women with vaginitis. Gynecol Obstet Invest 39, 67-69.
28. Sutton, P., Waring, P. & Müllbacher, A. (1996). Exacerbation of invasive aspergillosis by the immunosuppressive fungal metabolite, gliotoxin. Immunol Cell Biol 74, 318-322.
29. Test, S., Lampert, M., Ossanna, P., Thoene, J. & Weiss, S. (1984). Generation of nitrogen-chlorine oxidants by human phagocytes. J Clin Invest 74, 1341-1349.
30. Teuchner, B., Nagl, M., Schidlbauer, A. & 8 other authors (2005). Tolerability and efficacy of N-chlorotaurine in epidermic kerato-conjunctivitis - a double-blind, randomized, phase-2 clinical trial. J Ocul Pharmacol Ther 21, 157-165.
31. Wagner, D. K., Collins-Lech, C. & Sohnle, P. G. (1986). Inhibition of neutrophil killing of Candida albicans pseudohyphae by substances which quench hypochlorous acid and chloramines. Infect Immun 51, 731-735.
32. Waring, P. (1990). DNA fragmentation induced in macrophages by gliotoxin does not require protein synthesis and is preceded by raised inositol triphosphate levels. J Biol Chem 265, 14476-14480.
33. Waring, P. & Beaver, J. (1996). Gliotoxin and related epipolythio-dioxopipenmnes. Gen Pharmac 27, 1311-1316.
34. Waring, P., Eichner, R. D., Müllbacher, A. & Sjaarda, A. (1988). Gliotoxin induces apoptosis in macrophages unrelated to its antiphagocytic properties. J Biol Chem 263, 18493-18499.
35. Washburn, R. G., Gallin, J. I. & Bennett, J. E. (1987). Oxidative killing of Aspergillus fumigatus proceeds by parallel myeloperoxidase-dependent and independent pathways. Infect Immun 55, 2088-2092.
36. Watanabe, A., Kamei, K., Sekine, T., Waku, M., Nishimura, K., Miyaji, M. & Kuriyama, T. (2003). Immunosuppressive substances in Aspergillus fumigatus culture filtrate. J Infect Chemother 9, 114-121.
37. Weiss, S., Klein, R., Slivka, A. & Wei, M. (1982). Chlorination of taurine by human neutrophils. J Clin Invest 70, 598-607.